
    
      A Randomized, Double-Blind, Parallel Group, 52-week Study to Compare the Effect of the
      Fluticasone Propionate/Salmeterol DISKUS Combination Product 250/50mcg BID with Salmeterol
      DISKUS 50mcg BID on the Annual Rate of Moderate/Severe Exacerbations in Subjects with Chronic
      Obstructive Pulmonary Disease (COPD)
    
  